JP2002537816A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002537816A5 JP2002537816A5 JP2000602796A JP2000602796A JP2002537816A5 JP 2002537816 A5 JP2002537816 A5 JP 2002537816A5 JP 2000602796 A JP2000602796 A JP 2000602796A JP 2000602796 A JP2000602796 A JP 2000602796A JP 2002537816 A5 JP2002537816 A5 JP 2002537816A5
- Authority
- JP
- Japan
- Prior art keywords
- adenovirus
- subgroup
- recombinant
- serotype
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000701161 unidentified adenovirus Species 0.000 description 12
- 238000000034 method Methods 0.000 description 3
- 108090000565 Capsid Proteins Proteins 0.000 description 2
- 102100023321 Ceruloplasmin Human genes 0.000 description 2
- 210000000234 capsid Anatomy 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 108700026758 Adenovirus hexon capsid Proteins 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 101710145505 Fiber protein Proteins 0.000 description 1
- 241001135569 Human adenovirus 5 Species 0.000 description 1
- 208000003456 Juvenile Arthritis Diseases 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 210000002437 synoviocyte Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99200624.7 | 1999-03-04 | ||
| EP99200624 | 1999-03-04 | ||
| PCT/NL2000/000133 WO2000052186A1 (en) | 1999-03-04 | 2000-03-03 | Means and methods for fibroblast-like or macrophage-like cell transduction |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002537816A JP2002537816A (ja) | 2002-11-12 |
| JP2002537816A5 true JP2002537816A5 (https=) | 2011-02-24 |
| JP4683727B2 JP4683727B2 (ja) | 2011-05-18 |
Family
ID=8239945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000602796A Expired - Fee Related JP4683727B2 (ja) | 1999-03-04 | 2000-03-03 | 線維芽細胞様またはマクロファージ様細胞の形質導入のための手段と方法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1159438B1 (https=) |
| JP (1) | JP4683727B2 (https=) |
| AT (1) | ATE403006T1 (https=) |
| AU (1) | AU776067B2 (https=) |
| CA (1) | CA2364499C (https=) |
| DE (1) | DE60039683D1 (https=) |
| WO (1) | WO2000052186A1 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6783980B2 (en) | 1995-06-15 | 2004-08-31 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
| US6929946B1 (en) | 1998-11-20 | 2005-08-16 | Crucell Holland B.V. | Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
| US6869936B1 (en) | 1999-03-04 | 2005-03-22 | Crucell Holland B.V. | Means and methods for fibroblast-like or macrophage-like cell transduction |
| ES2372823T3 (es) * | 1999-05-17 | 2012-01-26 | Crucell Holland B.V. | Adenovirus recombinante del serotipo ad11. |
| US6492169B1 (en) | 1999-05-18 | 2002-12-10 | Crucell Holland, B.V. | Complementing cell lines |
| WO2003104467A1 (en) | 2002-04-25 | 2003-12-18 | Crucell Holland B.V. | Means and methods for the production of adenovirus vectors |
| US6913922B1 (en) | 1999-05-18 | 2005-07-05 | Crucell Holland B.V. | Serotype of adenovirus and uses thereof |
| EP1067188A1 (en) * | 1999-07-08 | 2001-01-10 | Introgene B.V. | Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 Coxsacki adenovirus receptor (CAR) |
| WO2002012523A2 (en) * | 2000-08-10 | 2002-02-14 | Crucell Holland B.V. | Transduction of chondrocytes using adenoviral vectors |
| CA2421864A1 (en) * | 2000-09-20 | 2002-03-28 | Crucell Holland B.V. | Transduction of dendritic cells using adenoviral vectors |
| DE60138403D1 (de) | 2000-09-26 | 2009-05-28 | Crucell Holland Bv | Adenovirale vektoren für die übertragung von genen in zellen der skelettmuskulatur oder myoblasten |
| AU2002211087A1 (en) * | 2000-10-06 | 2002-04-15 | Crucell Holland B.V. | Gene delivery vectors for stem cells |
| EP1195440A1 (en) * | 2000-10-06 | 2002-04-10 | Introgene B.V. | Gene delivery vectors for stem cells |
| US6905678B2 (en) | 2001-07-07 | 2005-06-14 | Crucell Holland B.V. | Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| EP1279738A1 (en) * | 2001-07-06 | 2003-01-29 | Crucell Holland B.V. | Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| EP1497440B1 (en) | 2002-04-25 | 2008-08-20 | Crucell Holland B.V. | Stable adenoviral vectors and methods for propagation thereof |
| AU2003288273A1 (en) | 2002-10-23 | 2004-05-13 | Crucell Holland B.V. | New settings for recombinant adenoviral-based vaccines |
| US20080153083A1 (en) | 2003-10-23 | 2008-06-26 | Crucell Holland B.V. | Settings for recombinant adenoviral-based vaccines |
| NZ539813A (en) | 2002-12-17 | 2008-04-30 | Crucell Holland Bv | A replication defective recombinant adenovirus comprising a antigenic determinant of Plasmodium falciparum wherein the antigenic determinant is SEQ ID 6 |
| SG11201507393TA (en) | 2013-03-14 | 2015-10-29 | Salk Inst For Biological Studi | Oncolytic adenovirus compositions |
| KR102608590B1 (ko) | 2014-09-24 | 2023-12-01 | 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 종양 살상 바이러스 및 이의 사용방법 |
| EP3359175B1 (en) | 2015-10-05 | 2020-09-16 | Salk Institute for Biological Studies | Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| WO2017147269A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics |
| EP3532082A4 (en) | 2016-12-12 | 2020-08-26 | Salk Institute for Biological Studies | SYNTHETIC ADENOVIRUS TUMOR TARGETING AND THEIR USES |
| WO2018125970A1 (en) * | 2016-12-30 | 2018-07-05 | Salk Institute For Biological Studies | Synthetic adenoviruses targeting bone tissue and uses thereof |
| JP7216668B2 (ja) | 2017-05-26 | 2023-02-01 | エピセントアールエックス，インコーポレイテッド | 導入遺伝子を保持する組換えアデノウイルス |
| CN112292449A (zh) | 2018-04-09 | 2021-01-29 | 萨克生物研究学院 | 具有增强的复制特性的溶瘤腺病毒组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2723697B1 (fr) * | 1994-08-17 | 1996-09-20 | Rhone Poulenc Rorer Sa | Methode de traitement de la restenose par la therapie genique |
| US5770442A (en) * | 1995-02-21 | 1998-06-23 | Cornell Research Foundation, Inc. | Chimeric adenoviral fiber protein and methods of using same |
| IL160406A0 (en) * | 1995-06-15 | 2004-07-25 | Crucell Holland Bv | A cell harbouring nucleic acid encoding adenoritus e1a and e1b gene products |
| EE9800160A (et) * | 1995-11-28 | 1998-12-15 | Genvec, Inc. | Vektorid ja meetodid geenide ülekandmiseks rakkudesse |
| US20030017138A1 (en) * | 1998-07-08 | 2003-01-23 | Menzo Havenga | Chimeric adenoviruses |
| EP1020529B1 (en) * | 1998-11-20 | 2005-06-01 | Crucell Holland B.V. | Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
| IL133032A (en) * | 1998-11-20 | 2007-06-03 | Introgene Bv | Adenoviral gene delivery vectors provided with a tissue tropism for smooth muscle cells and /or endothelial cells |
-
2000
- 2000-03-03 AU AU29488/00A patent/AU776067B2/en not_active Ceased
- 2000-03-03 WO PCT/NL2000/000133 patent/WO2000052186A1/en not_active Ceased
- 2000-03-03 AT AT00908116T patent/ATE403006T1/de not_active IP Right Cessation
- 2000-03-03 DE DE60039683T patent/DE60039683D1/de not_active Expired - Lifetime
- 2000-03-03 CA CA002364499A patent/CA2364499C/en not_active Expired - Fee Related
- 2000-03-03 JP JP2000602796A patent/JP4683727B2/ja not_active Expired - Fee Related
- 2000-03-03 EP EP00908116A patent/EP1159438B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002537816A5 (https=) | ||
| McCoy et al. | Pulmonary inflammation induced by incomplete or inactivated adenoviral particles | |
| Kreppel et al. | Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide | |
| JP4733795B2 (ja) | ヒツジアデノウイルスベクターを用いた遺伝子治療 | |
| CA2074502C (en) | Vaccines | |
| Tamanini et al. | Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells | |
| ATE403006T1 (de) | Verwendung eines adenovirusvektors zur transduktion von synovialen zellen | |
| DE59913833D1 (de) | Strukturprotein von aav, seine herstellung und verwendung | |
| JP2004501650A5 (https=) | ||
| WO2001055362A3 (en) | Hybrid adeno-retroviral vector for the transfection of cells | |
| Ohga et al. | Activin receptors are expressed on human lung fibroblast and activin A facilitates fibroblast-mediated collagen gel contraction | |
| DE69739211D1 (de) | Verpackungszellinien in der Verwendung zur Erleichterung der Entwicklung hocheffizienter adenoviraler Vektoren | |
| Flood et al. | Assembly of nucleocapsids with cytosolic and membrane-derived matrix proteins of vesicular stomatitis virus | |
| Mei et al. | Two closely related adenovirus genome types with kidney or respiratory tract tropism differ in their binding to epithelial cells of various origins | |
| JP2008508899A5 (https=) | ||
| WO2006033689A3 (en) | Aav mediated gene delivery to cochlear cells | |
| Verhaagh et al. | Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectors | |
| NO995697D0 (no) | Gen-vektorer | |
| Yao et al. | Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: evidence for prolonged stability and activity of the transgene in liver | |
| Fang et al. | Differences in the post‐translational modifications of human papillomavirus type 6b major capsid protein expressed from a baculovirus system compared with a vaccinia virus system | |
| Button et al. | Capsid-E2 interactions rescue core assembly in viruses that cannot form cytoplasmic nucleocapsid cores | |
| Mittal et al. | Pathology and immunogenicity in the cotton rat (Sigmodon hispidus) model after infection with a bovine adenovirus type 3 recombinant virus expressing the firefly luciferase gene | |
| WO2002008436A3 (en) | Mini-adenoviral vector system for vaccination | |
| WO2006086357A3 (en) | Adenovirus serotype 36 vectors, nucleic acid and viruses produced thereby | |
| AU1281902A (en) | Adenoviral vectors for gene delivery in skeletal muscle cells or myoblasts |